- Home
- BYAH vs DCOY Comparison
BYAH vs DCOY Comparison
Compare BYAH & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BYAH | DCOY |
|---|---|---|
| Founded | 2016 | N/A |
| Country | China | United States |
| Employees | 41 | 2 |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3M | 3.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BYAH | DCOY |
|---|---|---|
| Price | $1.02 | $5.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $30.00 |
| AVG Volume (30 Days) | ★ 54.7K | 18.5K |
| Earning Date | 03-02-2026 | 05-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.05 | $0.53 |
| 52 Week High | $2.77 | $9.09 |
Technical Indicators
Market Signals| Indicator | BYAH | DCOY |
|---|---|---|
| Relative Strength Index (RSI) | 46.39 | 50.80 |
| Support Level | $0.11 | $0.61 |
| Resistance Level | $2.77 | $7.50 |
| Average True Range (ATR) | 0.09 | 0.64 |
| MACD | -0.03 | -0.42 |
| Stochastic Oscillator | 31.39 | 8.99 |
Price Performance
Historical ComparisonAbout BYAH Park Ha Biological Technology Co. Ltd. Ordinary Shares
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales, and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha, in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complementary after-sales beauty services in its physical stores.
About DCOY Decoy Therapeutics Inc. Common Stock
Decoy Therapeutics Inc is a preclinical-stage biotechnology company developing peptide conjugate drug candidates using machine learning, artificial intelligence tools, and high-throughput synthesis techniques. The company's initial pipeline is focused on respiratory viruses and GI cancers.